Healthcare • Drug Manufacturers - General
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if GRFS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
20 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
164 filers reported a long position in GRFS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | $267.7M | 37.8M | +4.1% |
| Capital World Investors | $162.2M | 22.9M | -0.1% |
| Permian Investment Partners, LP | $139.8M | 19.7M | +2% |
| Black Creek Investment Management Inc. | $54.4M | 7.7M | -8.4% |
| BANK OF AMERICA CORP /DE/ | $46.4M | 6.6M | +51.4% |
| MILLENNIUM MANAGEMENT LLC | $30.9M | 4.4M | -12.7% |
| Flat Footed LLC | $30.8M | 4.3M | +216.9% |
| Jupiter Topco LLC | $20.9M | 3M | — |
| ARMISTICE CAPITAL, LLC | $20.8M | 2.9M | -1.7% |
| MORGAN STANLEY | $18.8M | 2.7M | -6.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.